BioSpace News Archive

Press Releases

Amphista Therapeutics presents new data demonstrating how its advanced Eclipsys® platform is delivering Targeted Glue™ degraders using novel E3 ligases into the clinic

February 26, 2026
·
4 min read
Press Releases

Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights

February 26, 2026
·
7 min read
Press Releases

Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics

February 26, 2026
·
3 min read
Press Releases

UK-China talks on Thermobalancing therapy for kidney stones, enlarged/inflamed prostate, back pain and joints problems

February 26, 2026
·
2 min read
Press Releases

TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance

February 26, 2026
·
25 min read
Press Releases

BioCryst Reports Full Year 2025 Financial Results and Provides Business Update

February 26, 2026
·
18 min read
Press Releases

Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results

February 26, 2026
·
23 min read
Press Releases

AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder

February 26, 2026
·
10 min read
Press Releases

TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03

February 26, 2026
·
7 min read
Press Releases

Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026

February 26, 2026
·
6 min read